| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.01B | 40.24B | 41.33B | 37.79B | 40.69B | 37.19B |
| Gross Profit | 13.59B | 12.35B | 13.62B | 11.65B | 11.97B | 11.04B |
| EBITDA | 7.05B | 4.84B | 6.28B | 5.05B | 5.94B | 5.68B |
| Net Income | 4.19B | 3.99B | 3.89B | 3.25B | 3.95B | 4.06B |
Balance Sheet | ||||||
| Total Assets | 47.21B | 50.69B | 47.83B | 44.08B | 40.37B | 37.75B |
| Cash, Cash Equivalents and Short-Term Investments | 10.54B | 11.88B | 10.88B | 10.23B | 7.23B | 6.91B |
| Total Debt | 3.60B | 3.38B | 4.12B | 488.47M | 600.25M | 2.90B |
| Total Liabilities | 12.68B | 12.09B | 13.39B | 7.58B | 7.03B | 10.28B |
| Stockholders Equity | 34.53B | 38.60B | 34.43B | 36.50B | 33.34B | 27.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.06B | 3.22B | 4.41B | 1.43B | 4.51B |
| Operating Cash Flow | 0.00 | 5.74B | 6.89B | 5.27B | 2.44B | 4.80B |
| Investing Cash Flow | 0.00 | -1.90B | -3.17B | -1.06B | -857.25M | -418.98M |
| Financing Cash Flow | 0.00 | -2.90B | -3.45B | -1.38B | -1.73B | -3.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥45.56B | 11.40 | ― | 3.36% | -2.63% | 5.35% | |
78 Outperform | ¥69.07B | 6.56 | 8.48% | 4.59% | -1.69% | 38.42% | |
74 Outperform | ¥526.52B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
70 Outperform | ¥379.89B | 12.15 | ― | 1.60% | -0.11% | -21.86% | |
69 Neutral | ¥111.82B | 12.01 | ― | 5.78% | 1.24% | 186.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥2.75B | 24.21 | ― | 3.03% | 2.78% | ― |